24 Jul, 2016 Clinically Meaningful Cognitive and Functional Improvements with Tramiprosate In Alzheimer’s Disease (AD) Patients with APOE4/4 Genotype: Subgroup Analyses from Two Phase 3 Studies alzheon2019-09-23T12:10:52-04:00July 24th, 2016| Read More
24 Jul, 2016 Phase 1 Development Of ALZ-801, a Novel Beta Amyloid Anti-aggregation Prodrug of Tramiprosate With Improved Drug Properties, Supporting Bridging to the Phase 3 Program alzheon2019-09-23T12:10:53-04:00July 24th, 2016| Read More